Peripheral arterial revascularization causing parallel increased activity of pro- and anti-inflammatory mediators

International Angiology

Volumn 26, Issue 1, 2007, Pages 8-11

  Parmar, J H ^a   Aslam, M ^a   Standfield, N J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Interleukins; Peripheral vascular disease; Reperfusion injury

Indexed keywords

ACETYLSALICYLIC ACID; INTERLEUKIN 10; INTERLEUKIN 6;

ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; BYPASS SURGERY; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PERIPHERAL VASCULAR DISEASE; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; REVASCULARIZATION; SUPERNATANT;

AGED; ANGIOPLASTY; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL ARTERY; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; MALE; PERIPHERAL VASCULAR DISEASES; REPERFUSION INJURY; TIME FACTORS; VASCULAR SURGICAL PROCEDURES;

EID: 34249826995     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wehrens XH, Rouwet EV, oude Egbrink MG, Slaaf DW, Ramsay G. Effects of experimental lower-limb ischaemia-reperfusion injury on the mesenteric microcirculation. Br J Surg 2002;89:185-91.
2. Forman MB, Puett DW, Virmani R. Endothelial and myocardial injury during ischaemia reperfusion: pathogenesis and therapeutic implications. J Am Coll Cardiol 1989;13:450-9.
3. Hearse DJ. Reperfusion of ischaemic myocardium. J Mol Cell Cardiol 1977;9:605-16.
4. Grace PA, Mathie R, editors. Ischaemia reperfusion injury. Oxford: Blackwell Science Ltd.; 1999.
5. Rowlands TE, Homer-Vanniasinkam S. Pro- and anti-inflammatory cytokine release in open versus endovascular repair of abdominal aortic aneurysm. Br J Surg 2001;88:1335-40.
6. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996;24:163-72.
7. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 1990;4:2860-7.
8. Heath DI, Cruickshank A, Imrie CW. Role of IL-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-5.
9. Schulter B, Konig B, Konig W, Il-6 a potential mediator of lethal sepsis after major thermal trauma: evidence for increased production by peripheral blood mononuclear cells. J Trauma 1991;31:1663-70.
10. Kuster H, Weiss M, Willeitner AE, Detlefsen S, Jeremias I, Zbojan J et al. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 1998;352:1271-7.
11. de Bont ES, Vellenga E, Swaanenburg JC, Fidler V, Visser-van Brummen PJ, Kamps WA. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol 1999;107:375-80.
12. Florintino FD, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
13. Moore KW, O'Garra A, de Waal Malefyt R, Vierra P, Mossman TR. IL-10. Annu Rev Immunol 1993;11:165-90.
14. Cassatella MA. The neutrophil: one of the cellular targets of IL-10. Int J Clin Lab Res 1998;28:148-61.
15. Hess PJ, Seeger JM, Huber TS, Welborn MB, Martin TD, Harward TR et al. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia. J Vasc Surg 1997;26:113-8.
16. Friedman G, Jankowski S, Merchant A, Vincent JL. Blood IL-10 levels parallel the severity of septic shock. J Crit Care 1997;12:183-7.
17. Haupt W, Zirngibl H, Hohenberger W. TNF alpha and Il-10 production in septic patients and the regulatory effect of plasma. Eur J Surg 1999;165:95-100.